We are currently offering a comprehensive panel of antibodies specific for human Norovirus, including GII.4 2012 Sydney strain. MAB223P through MAB228P have been tested across a broad range of strains, as reported in the table below. In addition to being broadly cross reactive to GII.4 genotypes, MAB227P has demonstrated the ability to block ligand binding in surrogate neutralization assays. MAB228P, developed against GI.1 1968 virus like particles (VLPs), has been shown to recognize additional GI types. There are currently five known genogroups, of which three cause human disease: GI, GII, and GIV. According to the CDC, since 2002 GII.4 has been the most common cause of Norovirus outbreaks.







